Skip to Main Content

Clinical Research Services

The Yale Cancer Center Clinical Research Services provides centralized, integrated, and coordinated support for cancer clinical trials conducted throughout the Yale Cancer Center/Smilow Cancer Hospital Network with the goals of promoting quality research, safeguarding participant safety, and ensuring fiscal and regulatory compliance.

Patients enrolled in cancer clinical trials are most frequently cared for at Smilow Cancer Hospital and at the Smilow Cancer Hospital Network Sites throughout Connecticut. Yale Cancer Center’s clinical trial portfolio includes over 250 active trials, providing options beyond the standard of care for patients with most types of cancers.

Clinical Research Services is comprised of the Yale Cancer Center Clinical Trials Office, as well as resources for contracts, budgeting and protocol development. This resource provides the infrastructure necessary to support high-quality clinical trials and translational research. The staff of clinical research professionals offers complete support for clinical trials including preparation and submission of protocols to review committees, establishment and maintenance of case and regulatory research files, completion of Case Report Forms, data entry, preparation of reports and analysis, coordination of monitoring visits and audits, as well as education, monitoring and follow-up. The staff has expertise in coordinating industry-supported, NCI cooperative group, and Investigator-Initiated studies.


Ian Krop, MD, PhD; Director, Clinical Trials Office; Associate Cancer Center Director for Clinical Research; Chief Clinical Research Officer


Alyssa K. Gateman, MPH, CCRP; Executive Director, Clinical Trials Office, Yale Cancer Center